Diagnosis of stomach cancer (also known as gastric cancer) is now occurring more often at earlier stages, likely related to advances in tests and imaging. Importantly, stomach cancer is also being ...

Multi-cancer blood tests promise early detection, but the evidence is thin, the risks real, and they’re no substitute for listening to your body.

If you have anxiety and self-doubt, there is more happening behind the scenes than you realize. Problematic core beliefs, ...

Strengthening awareness about complete blood report interpretation among both healthcare providers and patients may help ...

The numerous health benefits of blood testing include screening and prevention, particularly with high cholesterol, blood glucose, and elevated hormone levels. By analyzing your blood test results, ...

While it's common knowledge that Neanderthals and modern humans interbred long ago, a new genetic study is suggesting that among the Neanderthals, their modern human blood came mostly from the moms in ...

New research shows a simple blood test can predict the onset of Alzheimer’s symptoms, leading to earlier therapeutic care Cara Lynn Shultz is a writer-reporter at PEOPLE. Her work has previously ...

A new study conducted by Washington University School of Medicine in St. Louis researchers found that a single blood test could predict when someone is likely to develop Alzheimer’s disease. The study ...

A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in diagnoses at later stages of the disease. By Rebecca Robbins and Gina Kolata A ...

WashU researchers have created a model that can seemingly predict a person's symptoms of Alzheimer's within a few years. Reading time 3 minutes Sickness and death are inevitable, but many of us will ...

A simple blood test might one day serve as a molecular ‘clock’ that predicts not only whether someone will develop Alzheimer’s disease — but when. Blood tests are now approved for Alzheimer’s: how ...

Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT in 2021 after covering health and science at NPR and NPR affiliate stations. His ...